Chintan Aundhia

Chintan Aundhia

Auto-generated profile, based on publicly available information

Chintan Aundhia

Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Piparia, Waghodia, Vadodara, 391760, Gujarat, India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2025 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
CAChintan Aundhia
Chintan Aundhia
Ghanshyam ParmarGhanshyam Parmar
Ghanshyam Parmar
CTChitrali Talele
Chitrali Talele
NSNiyati Shah
Niyati Shah
DTDipali Talele
Dipali Talele
This review explores the transformative impact of AI on drug development and delivery in pharmaceutical sciences, spanning formulation design, real-time monitoring, targeted delivery, and future prospects. The rational design of smart drug carriers, such as AI-optimized liposomes for cancer therapy, optimizes formulations for individual patient needs. AI-driven sensors, exemplified by glucose-monitoring biosensors for diabetics, enable adaptive drug administration, enhancing precision. Despite promises, challenges like biocompatibility, regulations, and ethics persist. Interdisciplinary collaboration and transparent communication are crucial for responsible AI adoption. Anticipated trends include personalized dosage optimization and intelligent nanocarriers. The review underscores AI's potential in reshaping pharmaceuticals for patient-centric care while addressing challenges for widespread adoption.

1 August 2024 in Current Organic Chemistry
Verified
Journal Article
Closed access
PDF file
CAChintan Aundhia
Chintan Aundhia
GPGhanshyam Parmar
Ghanshyam Parmar
CTChitrali Talele
Chitrali Talele
SKSunil Kardani
Sunil Kardani
RMRajesh Maheshwari
Rajesh Maheshwari
Photoresponsive polymers have emerged as innovative tools in the domain of drug delivery, presenting advanced solutions for controlled and targeted release of therapeutic agents. This review explores recent advances in the design and application of photoresponsive polymers, focusing on their pivotal role in light-triggered drug delivery systems. It also encompasses organic synthesis methodologies, key advancements in polymer design, and the integration of photoresponsive elements into drug carriers. Moreover, this review also focuses on the applications, challenges, and future prospects, providing a comprehensive overview of the evolving landscape of light-responsive drug delivery technologies. The information about the synthesis presented herein aims to contribute to the understanding and advancement of this dynamic field, offering insights for researchers and practitioners engaged in the development of next-generation drug delivery systems.

1 January 2025 in Current Nanoscience
Verified
Journal Article
Closed access
PDF file
Ghanshyam ParmarGhanshyam Parmar
Ghanshyam Parmar
JCJay Mukesh Chudasama
Jay Mukesh Chudasama
CAChintan Aundhia
Chintan Aundhia
The pharmaceutical sciences are gradually shielding mankind from a plethora of deadly but as-of-yet-undiscovered ailments. Many diseases, some of which can be fatal, have their initial line of defence on the skin. A significant challenge for scientists is the development of appropriate pharmacological formulations for transdermal drug administration. Low side effect risk reduces first-pass impact, and good patient compliance makes transdermal distribution superior to oral delivery. This is why transdermal medication delivery is so important. Thanks to advancements in pharmaceutical delivery systems, the skin can now absorb medications more effectively. Researchers from different parts of the globe have investigated many different kinds of medications as possible transdermal delivery routes using electrospinning nanofibres. The skin can more easily absorb therapeutic compounds thanks to the nanofibres' ability to concentrate them. It is possible to load hydrophilic and lipophilic medications onto polymeric nanofibres. Another option is the transdermal distribution of biopolymer nanofibres. Over long periods of time, they control the release of medicinal substances. Nanofibres and nanoparticles allow for the controlled release of both hydrophobic and hydrophilic drugs. Transdermal and topical medication delivery using polymeric electrospinning nanofibres laden with nanoparticles and medicines is the subject of this research review. After that, we'll look at some practical instances of engineers using electrospinning fibres to control the release of drugs in reaction to environmental and internal factors. Afterwards, we will quickly go over the latest developments in tissue engineering, hard tissue engineering (which includes repairing musculoskeletal systems, bones, and cartilage), and cancer therapy that uses electrospin nanofiber scaffolds to control the distribution of drugs. Thanks to recent advancements in medicine and pharmaceuticals, nanofibres may soon be able to transport a wide variety of drugs, allowing for more targeted methods of cellular regeneration and topical medication delivery.

21 August 2025 in Recent Advances in Drug Delivery and Formulation
Verified
Journal Article
Closed access
PDF file
CAChintan Aundhia
Chintan Aundhia
Ghanshyam ParmarGhanshyam Parmar
Ghanshyam Parmar
CTChitrali Talele
Chitrali Talele
PSPiyushkumar Sadhu
Piyushkumar Sadhu
ASAvinshkumar Seth
Avinshkumar Seth
The acidic nature of tumor microenvironments presents a unique opportunity for the targeted delivery of therapeutics using pH-responsive polymeric nanocarriers. These smart nanocarriers are designed to release their payload specifically in response to the low pH found in tumor tissues, thereby enhancing drug accumulation at the tumor site while minimizing systemic side effects. This review provides a comprehensive overview of the design principles, fabrication methods, and applications of pH-responsive polymeric nanocarriers for targeted drug delivery in tumor microenvironments. Key topics include the mechanisms of pH-responsive drug release, engineering strategies for developing pH-sensitive polymers, and recent advancements in exploiting tumor acidity for improved therapeutic outcomes. Additionally, the review discusses the clinical potential and the challenges associated with the translation of these nanocarriers from bench to bedside.

1 February 2025 in Pharmaceutical Nanotechnology
Verified
Journal Article
Closed access
PDF file
CAChintan Aundhia
Chintan Aundhia
NSNirmal Shah
Nirmal Shah
CTChitrali Talele
Chitrali Talele
AZAarti Zanwar
Aarti Zanwar
MKMamta Kumari
Mamta Kumari
SPSapana Patil
Sapana Patil
Gene therapy is a revolutionary approach aimed at treating various diseases by manipulating the expression of specific genes. The composition and formulation of ultra-deformable vesicles play a crucial role in determining their properties and performance as siRNA delivery vectors. In the development of ultra-deformable vesicles for siRNA delivery, careful lipid selection and optimization are crucial for achieving desirable vesicle characteristics and efficient siRNA encapsulation and delivery. The stratum corneum acts as a protective barrier, limiting the penetration of molecules, including siRNA, into the deeper layers of the skin. Ultradeformable vesicles offer a promising solution to overcome this barrier and facilitate efficient siRNA delivery to target cells in the skin. The stratum corneum, the outermost layer of the skin, acts as a significant barrier to the penetration of siRNA.These engineering approaches enable the production of uniform and well-defined vesicles with enhanced deformability and improved siRNA encapsulation efficiency. Looking ahead, advancements in ultra-deformable vesicle design and optimization, along with continued exploration of combination strategies and regulatory frameworks, will further drive the field of ultra-deformable vesicle-based siRNA delivery.

1 November 2026 in Current Drug Targets
Verified
Journal Article
Closed access
CAChintan Aundhia
Chintan Aundhia
Ghanshyam ParmarGhanshyam Parmar
Ghanshyam Parmar
CTChitrali Talele
Chitrali Talele
MKMamta Kumari
Mamta Kumari
GGGaurav Gupta
Gaurav Gupta
Introduction: This review aims to comprehensively discuss the emerging role of artificial intelligence (AI) and three-dimensional (3D) printing in the design and development of personalized polymeric nanocomposite-based drug delivery systems. The focus is on how integrating these technologies enhances the precision, efficacy, and customization of pharmacotherapy compared with conventional formulations. Methods: An extensive literature survey was conducted using databases such as PubMed, Scopus, Web of Science, and ScienceDirect, focusing on publications from the past decade. Peer-reviewed studies, reviews, and reports on polymeric nanocomposites, AI-based formulation design, and 3Dprinted drug delivery systems were critically analyzed. The collected data were synthesized to elucidate design principles, fabrication methods, and the synergistic application of AI and 3D printing in personalized medicine. Results: Polymeric nanocomposites have demonstrated superior performance in targeted and controlled drug release due to their adaptable physicochemical properties and biocompatibility. The application of AI enables predictive modeling, optimization of formulation parameters, and patient stratification through data-driven algorithms. Concurrently, 3D printing enables the fabrication of patient-specific dosage forms and implants with programmable drug-release profiles. Together, these technologies enable the development of individualized therapeutic systems that enhance treatment outcomes and minimize adverse effects. Discussion: This synergistic incorporation of AI and additive manufacturing tackles some of the main obstacles in precision medicine by diminishing trial-and-error in formulation, enhancing reproducibility, and promoting better outcomes during treatment. Such multidisciplinary applications are most promising in cancer, diabetes, neurodegenerative, infectious, and cardiovascular diseases. Conclusion: The integration of AI and 3D printing represents a transformative advancement in personalized nanocomposite drug delivery. These interdisciplinary approaches collectively enable precise control over drug release kinetics, dosage customization, and formulation design. Future developments focusing on regulatory standardization, ethical data use, and large-scale clinical translation will further accelerate the adoption of AI- and 3D-printing-assisted personalized drug delivery systems in clinical practice. While these technologies hold great potential for personalized and precise therapeutics, their clinical translation remains challenged by regulatory validation, manufacturing reproducibility, and data transparency requirements.